Similar articles for PMID: 20191576

Year	Number of Results
1992	1
1995	1
2002	2
2003	1
2004	2
2005	2
2006	4
2007	5
2008	9
2009	7
2010	7
2011	10
2012	18
2013	13
2014	19
2015	13
2016	13
2017	6
2018	10
2019	1
2020	3
2021	8
2022	8
2023	5
2024	0

1

Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease.

Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Khosroshahi A, et al. Arthritis Rheum. 2010 Jun;62(6):1755-62. doi: 10.1002/art.27435. Arthritis Rheum. 2010. PMID: 20191576 Free article.

2

Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients.

Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Khosroshahi A, et al. Medicine (Baltimore). 2012 Jan;91(1):57-66. doi: 10.1097/MD.0b013e3182431ef6. Medicine (Baltimore). 2012. PMID: 22210556 Free article. Clinical Trial.

3

Rituximab for IgG4-related disease: a prospective, open-label trial.

Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, Deshpande V, Smyrk TC, Chari S, Stone JH. Carruthers MN, et al. Ann Rheum Dis. 2015 Jun;74(6):1171-7. doi: 10.1136/annrheumdis-2014-206605. Epub 2015 Feb 9. Ann Rheum Dis. 2015. PMID: 25667206

4

Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis.

Marino M, Basile U, Spagni G, Napodano C, Iorio R, Gulli F, Todi L, Provenzano C, Bartoccioni E, Evoli A. Marino M, et al. Front Immunol. 2020 May 5;11:613. doi: 10.3389/fimmu.2020.00613. eCollection 2020. Front Immunol. 2020. PMID: 32431692 Free PMC article.

5

IgG4-related disease.

Mahajan VS, Mattoo H, Deshpande V, Pillai SS, Stone JH. Mahajan VS, et al. Annu Rev Pathol. 2014;9:315-47. doi: 10.1146/annurev-pathol-012513-104708. Epub 2013 Oct 2. Annu Rev Pathol. 2014. PMID: 24111912 Review.

6

Rituximab for the Treatment of IgG4-Related Tubulointerstitial Nephritis: Case Report and Review of the Literature.

McMahon BA, Novick T, Scheel PJ, Bagnasco S, Atta MG. McMahon BA, et al. Medicine (Baltimore). 2015 Aug;94(32):e1366. doi: 10.1097/MD.0000000000001366. Medicine (Baltimore). 2015. PMID: 26266393 Free PMC article. Review.

7

[IgG4-related disease: patient group characterization and rituximab therapy].

Sedyshev SKh, Vasil'ev VI, Kovrigina AM, Logvinenko OA, Rodionova EB, Safonova TN, Gaĭduk IV, Silin AIu, Komov DV, Nasonov EL. Sedyshev SKh, et al. Ter Arkh. 2013;85(2):48-53. Ter Arkh. 2013. PMID: 23653939 Russian.

8

Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab.

Fraticelli P, De Vita S, Franzolini N, Svegliati S, Scott CA, Tonnini C, Spadoni T, Gabrielli B, Pomponio G, Moroncini G, Gabrielli A. Fraticelli P, et al. Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S160-7. Epub 2015 Sep 1. Clin Exp Rheumatol. 2015. PMID: 26339895

9

B cell depletion with rituximab in patients with rheumatoid arthritis: Multiplex bead array reveals the kinetics of IgG and IgA antibodies to citrullinated antigens.

Cambridge G, Leandro MJ, Lahey LJ, Fairhead T, Robinson WH, Sokolove J. Cambridge G, et al. J Autoimmun. 2016 Jun;70:22-30. doi: 10.1016/j.jaut.2016.03.010. Epub 2016 Apr 4. J Autoimmun. 2016. PMID: 27055777

10

Rituximab for the treatment of IgG4-related orbital disease: experience from five cases.

Wu A, Andrew NH, Tsirbas A, Tan P, Gajdatsy A, Selva D. Wu A, et al. Eye (Lond). 2015 Jan;29(1):122-8. doi: 10.1038/eye.2014.251. Epub 2014 Oct 24. Eye (Lond). 2015. PMID: 25341435 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

141 results

Results by year